BDBM416349 (4S)-4-(1-methylethy])-3-(6-{[4- (trifluoromethyl)cyclohexyl]- carbonyl}-6,11-dihydro-5H- pyrido[2,3-b][1,5]benzodiazepin- 8-yl)-1,3-oxazolidin-2-one::US10442819, Example 493

SMILES CC(C)[C@H]1OCC(=O)N1c1ccc2Nc3ncccc3CN(C(=O)C3CCC(CC3)C(F)(F)F)c2c1

InChI Key InChIKey=RTEPQPQUHQFUTC-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 416349   

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132H](Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM416349(US10442819, Example 493 | (4S)-4-(1-methylethy])-3...)
Affinity DataIC50: 4nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
US Patent